Abiopharma

🔍 McPherron Aviva (Executive)

Company: Orthofix Medical Inc. (OFIX)

Report Date: 2026-06-18

Detailed Transactions and Holdings:

• Sold 3,670 shares of Common Stock at $9.38 per share (Direct)
  Date: 2026-06-18 | Code: S | equity_swap_involved: false | shares_owned_after: 66,330.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person.
• F2: Includes 44,748 previously reported restricted stock units and 2,147 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).